Aytu Biopharma (AYTU) Net Margin (2013 - 2025)
Aytu Biopharma (AYTU) posted quarterly Net Margin of 0.41% for Q2 2025, up 890.0% year-over-year from 0.04% in Q2 2024, and up 39.98% quarter-over-quarter from 0.29% in Q1 2025.
Aytu Biopharma (AYTU) Net Margin (2013 - 2025) Analysis & Trends
Aytu Biopharma (AYTU) has reported Net Margin for 13 consecutive years, with 0.41% the latest figure, recorded in Q2 2025.
- In Q2 2025, Net Margin rose 890.0% year-over-year to 0.41%; the TTM figure through Mar 2026 stood at 0.11% (up 114.0% YoY), while the FY2025 annual figure was 0.93%, up 603.0% from the prior year.
- Net Margin grew to 0.41% in Q2 2025 per AYTU's latest filing, from 0.29% in the prior quarter.
- Across five years, Net Margin topped out at 25.36% in Q2 2022 and bottomed at 220.22% in Q1 2022.
- Historically, Net Margin has averaged 31.56% across 5 years, with a median of 4.48% in 2023.
- Annual changes were most pronounced in 2021 — Net Margin plunged 9534 bps — and 2023, when it surged 18855 bps.
- Aytu Biopharma's Net Margin stood at 49.94% in 2021, then soared by 49 bps to 25.47% in 2022, then soared by 82 bps to 4.48% in 2023, then surged by 117 bps to 0.76% in 2024, then sank by 46 bps to 0.41% in 2025.
- Business Quant data shows AYTU's Net Margin at 0.41% in Q2 2025, 0.29% in Q1 2025, and 0.76% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Aytu Biopharma | 24.81 Mn | -1.91 Mn | 7.60 Mn | -45.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.41% |
| Mar 31, 2025 | 0.29% |
| Dec 31, 2024 | 0.76% |
| Sep 30, 2024 | 2.30% |
| Jun 30, 2024 | -8.49% |
| Mar 31, 2024 | -4.27% |
| Dec 31, 2023 | -4.48% |
| Sep 30, 2023 | -3.63% |
| Jun 30, 2023 | -7.99% |
| Mar 31, 2023 | -31.67% |
| Dec 31, 2022 | -25.47% |
| Sep 30, 2022 | -2.53% |
| Jun 30, 2022 | 25.36% |
| Mar 31, 2022 | -220.22% |
| Dec 31, 2021 | -49.94% |
| Sep 30, 2021 | -127.19% |
| Jun 30, 2021 | -79.80% |
| Dec 31, 2020 | -62.88% |
| Sep 30, 2020 | -31.85% |
| Jun 30, 2020 | -49.00% |